AngioDynamics (ANGO, Financial) experienced a significant stock movement with a 5.05% increase in its share price, bringing it to $6.87 per share. The trading volume reached 382,665 shares, reflecting a turnover rate of 0.94% and a price fluctuation of 6.12%.
Financially, AngioDynamics reported a revenue of $67.49 million but faced a net loss of $12.80 million, resulting in an earnings per share (EPS) of -$0.31. The company's gross profit stood at $34.15 million, with a negative price-to-earnings (P/E) ratio of -1.14.
Analyst ratings are favorable for AngioDynamics, with all participating institutions providing a "buy" recommendation. No analysts have given a "hold" or "sell" rating.
Within the medical device sector, where AngioDynamics operates, the overall decline was 0.13%. Despite this, AngioDynamics, along with Innovative Eyewear, Inc. and Sanara Medtech Inc., showed notable gains. Other active stocks in the sector included Sharps Technology Inc., American International, and Bionano Genomics, Inc., with varying turnover rates. American International, Zentek Ltd., and Sharps Technology Inc. had the most significant price fluctuations.
AngioDynamics Inc. specializes in designing, manufacturing, and selling medical, surgical, and diagnostic devices primarily for peripheral vascular disease treatment, oncology, and surgical procedures, with most revenue generated from U.S. sales of Med Tech and Med Device products.
